Calcium channels as pharmacological targets for cancer therapy

Xiaozhen Liu1, Changyun Feng2, Li Yan1

  • 1Department of Medical and Radiation Oncology, Linyi People's Hospital, Linyi, 276000, China.

Insights

Calcium ions (Ca2+) are vital cell messengers. Dysregulated calcium signaling drives cancer, but targeting Ca2+ channels offers new therapeutic strategies for cancer treatment.

Area of Science:

  • Biochemistry and Molecular Biology
  • Cellular Physiology
  • Cancer Biology

Background:

  • Calcium ions (Ca2+) function as critical second messengers in numerous biological processes.
  • Aberrant calcium signaling pathways are implicated in the development and progression of various cancers.
  • Ca2+ influences cell death and proliferation, making it a potential target for cancer therapy.

Purpose of the Study:

  • To review the classification and mechanisms of calcium channels in oncogenesis.
  • To explore the therapeutic potential of calcium channel blockers in cancer treatment.
  • To highlight the need for further clinical investigations.

Main Methods:

  • Literature review of calcium channel classification and function.
  • Analysis of calcium signaling's role in cancer progression.
  • Examination of existing and potential applications of calcium blockers in oncology.

Main Results:

  • Calcium channels are diverse and play distinct roles in cancer development.
  • Dysregulation of Ca2+ homeostasis is a hallmark of many cancers.
  • Calcium channel blockers show promise as a novel therapeutic approach.

Conclusions:

  • Understanding calcium channel subtypes and their roles in cancer is crucial.
  • Targeting calcium signaling pathways presents a viable strategy for novel cancer therapeutics.
  • Further clinical trials are essential to validate the efficacy of calcium blockers in cancer treatment.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
418
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
6.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K